Previously, FBXW5 was proposed to form a complex with CUL4A in non-small cell lung cancer, which led to the degradation of the tumor suppressor protein, DLC1, a Rho GTPase-activating protein, ultimately promoting cell proliferation [13]. Here, FBXW5 is linked to non-small cell lung carcinoma.